129 related articles for article (PubMed ID: 937013)
21. Studies on antihyperlipidemic agents. II. Synthesis and biological activities of 2-chloro-3-arylpropionic acids.
Kawamatsu Y; Asakawa H; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
Arzneimittelforschung; 1980; 30(4):585-9. PubMed ID: 7190396
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents.
Gupta D; Ghosh NN; Chandra R
Bioorg Med Chem Lett; 2005 Feb; 15(4):1019-22. PubMed ID: 15686904
[TBL] [Abstract][Full Text] [Related]
23. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
[TBL] [Abstract][Full Text] [Related]
24. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
[TBL] [Abstract][Full Text] [Related]
25. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
[TBL] [Abstract][Full Text] [Related]
26. Ethyl 2-([5,6-dihydro-7-(1H-imidazol-1-yl)-2-naphthalenyl]oxy)- 2-methylpropanoate as a new potent oxyisobutyrate hypolipidaemic with unusual features.
Cozzi P; Branzoli U; Carganico G; Chiari A; Lovisolo PP; Severino D
Farmaco Sci; 1987 Mar; 42(3):205-18. PubMed ID: 3653387
[TBL] [Abstract][Full Text] [Related]
27. Proceedings: Potentiating of lipid lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
Simane Z; Nowak H
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R94. PubMed ID: 4276652
[No Abstract] [Full Text] [Related]
28. HCG 004, a new highly potent hypolipidaemic drug.
Granzer E; Nahm H
Arzneimittelforschung; 1973 Sep; 23(9):1353-4. PubMed ID: 4801238
[No Abstract] [Full Text] [Related]
29. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
31. The mouse as a model for evaluation of hypotriglyceridemic drugs effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
Gustafsson K; Kiessling H
Z Versuchstierkd; 1982; 24(5-6):271-7. PubMed ID: 7170839
[No Abstract] [Full Text] [Related]
32. [Effect on lipidemia in the rat of bis-homoanalogs of adenine nucleosides].
Gaggi R; Giovanninetti G; Cavrini V; Garuti L; Roveri P; Amorosa M; Defaye J
Farmaco Sci; 1980 Jul; 35(7):581-9. PubMed ID: 7450047
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological study of antihyperlipaemic activity of 2-substituted thieno(2,3-d)pyrimidin-4(3H)-ones.
Shishoo CJ; Devani MB; Bhadti VS; Jain KS; Rathod IS; Goyal RK; Gandhi TP; Patel RB; Naik SR
Arzneimittelforschung; 1990 May; 40(5):567-72. PubMed ID: 2383297
[TBL] [Abstract][Full Text] [Related]
34. Structure/activity relationship of gemfibrozil (CI-719) and related compounds.
Creger PL; Moersch GW; Neuklis WA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):3-5. PubMed ID: 1019152
[No Abstract] [Full Text] [Related]
35. [Aryloxy- and arylthioalkylamine hypolipidemic agents].
Duranti E; Bonifazi P; Salvatori A; Balsamini C; Peruzzi G; Cantoni O
Farmaco Sci; 1983 Sep; 38(9):664-71. PubMed ID: 6641932
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and hypolipidemic activity of some new esters of glycerol and 2-O-methyl-glycerol with nicotinic and 5-fluoro-nicotinic acids.
Dall'Asta L; Comini A; Borella F; Berti MA; Coppi G
Boll Chim Farm; 1989 Mar; 128(3):106-10. PubMed ID: 2775523
[TBL] [Abstract][Full Text] [Related]
37. [Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)].
de la Fuente R; Santos M
Arch Farmacol Toxicol; 1980 Dec; 6(3):255-64. PubMed ID: 7305456
[No Abstract] [Full Text] [Related]
38. Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178).
Gurrieri J; Lous ML; Renson FJ; Tourne C; Voegelin H; Majoie B; Wüfert E
Arzneimittelforschung; 1976; 26(5):889-94. PubMed ID: 989363
[TBL] [Abstract][Full Text] [Related]
39. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
Metz G; Specker M
Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
[TBL] [Abstract][Full Text] [Related]
40. Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity.
Shi GQ; Dropinski JF; Zhang Y; Santini C; Sahoo SP; Berger JP; Macnaul KL; Zhou G; Agrawal A; Alvaro R; Cai TQ; Hernandez M; Wright SD; Moller DE; Heck JV; Meinke PT
J Med Chem; 2005 Aug; 48(17):5589-99. PubMed ID: 16107159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
